Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
5.26
+0.46 (9.58%)
At close: Mar 9, 2026, 4:00 PM EDT
5.28
+0.02 (0.38%)
After-hours: Mar 9, 2026, 7:49 PM EDT

Aldeyra Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-33.85-55.85-37.54-62.02-57.78
Upgrade
Depreciation & Amortization
0.250.250.260.260.26
Upgrade
Other Amortization
0.27----
Upgrade
Loss (Gain) From Sale of Investments
-1.15-1.67-0.01-0.05-
Upgrade
Stock-Based Compensation
6.097.975.758.297.11
Upgrade
Other Operating Activities
0.220.180.350.330.41
Upgrade
Change in Accounts Payable
-0.02-1.161.2-0.890.64
Upgrade
Change in Unearned Revenue
--6--
Upgrade
Change in Other Net Operating Assets
-5.167.07-6.34-2.566.8
Upgrade
Operating Cash Flow
-33.35-43.21-30.33-56.64-42.56
Upgrade
Capital Expenditures
----0.02-0.01
Upgrade
Investment in Securities
47.74-44.9230-29.94-
Upgrade
Investing Cash Flow
47.74-44.9230-29.95-0.01
Upgrade
Long-Term Debt Repaid
--0.29-1.04--
Upgrade
Net Debt Issued (Repaid)
--0.29-1.04--
Upgrade
Issuance of Common Stock
1.120.390.311.22194.5
Upgrade
Repurchase of Common Stock
---0.53--
Upgrade
Other Financing Activities
--0.27---
Upgrade
Financing Cash Flow
1.12-0.17-1.271.22194.5
Upgrade
Net Cash Flow
15.51-88.3-1.6-85.37151.93
Upgrade
Free Cash Flow
-33.35-43.21-30.33-56.65-42.56
Upgrade
Free Cash Flow Per Share
-0.56-0.73-0.51-0.97-0.79
Upgrade
Cash Interest Paid
1.691.751.71.341.34
Upgrade
Levered Free Cash Flow
-21.46-17.06-27.6292.19-123.6
Upgrade
Unlevered Free Cash Flow
-20.27-15.86-26.3293.25-122.51
Upgrade
Change in Working Capital
-5.185.910.86-3.447.44
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.